University of Alberta-ko ikertzaileekin lankidetzan egindako argitalpenak (1)

2020

  1. Randomized Phase II Study of Paclitaxel plus Alisertib versus Paclitaxel plus Placebo as Second-Line Therapy for SCLC: Primary and Correlative Biomarker Analyses

    Journal of Thoracic Oncology